By Ryan Davis ( January 12, 2016, 9:24 PM EST) -- The Patent Trial and Appeal Board decided Monday to begin a proceeding to determine who was the first to invent the breakthrough gene-editing technology known as CRISPR, setting the stage for a winner-take-all showdown between major universities in a fairly obscure patent arena, with billions of dollars in licensing revenue at stake....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.